{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:02:34Z","timestamp":1790647354143,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00669-z","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:40:50Z","timestamp":1790646050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colistin therapy and survival outcomes in neonatal carbapenem-resistant gram-negative sepsis"],"prefix":"10.1007","volume":"34","author":[{"given":"Seyyed Mohammad Hassan","family":"Aletayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Dehdashtian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-9167","authenticated-orcid":false,"given":"Arash","family":"Malakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Aramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"12","key":"669_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance\u2014the need for global solutions. Lancet Infect Dis. 2013;13(12):1057\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"669_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/archdischild-2012-302033","volume":"98","author":"L Downie","year":"2013","unstructured":"Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO\u2019s currently recommended antibiotics. Arch Dis Child. 2013;98(2):146\u201350.","journal-title":"Arch Dis Child"},{"issue":"1","key":"669_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-0038-1677535","volume":"8","author":"L Folgori","year":"2019","unstructured":"Folgori L, Bielicki J. Future challenges in pediatric and neonatal sepsis: emerging pathogens and antimicrobial resistance. J Pediatr Intensive Care. 2019;8(1):17\u201324.","journal-title":"J Pediatr Intensive Care"},{"issue":"9465","key":"669_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(05)71881-X","volume":"365","author":"AK Zaidi","year":"2005","unstructured":"Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365(9465):1175\u201388.","journal-title":"Lancet"},{"issue":"9","key":"669_CR5","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333\u201341.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"669_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589\u2013601.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"669_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","volume":"22","author":"RL Nation","year":"2009","unstructured":"Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009;22(6):535\u201343.","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"669_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1345\/aph.18426","volume":"33","author":"ME Evans","year":"1999","unstructured":"Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999;33(9):960\u20137.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"669_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1179\/joc.2003.15.2.129","volume":"15","author":"A Giacometti","year":"2003","unstructured":"Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, D\u2019amato G, et al. Antiendotoxin activity of antimicrobial peptides and glycopeptides. J Chemother. 2003;15(2):129\u201333.","journal-title":"J Chemother"},{"issue":"14","key":"669_CR10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2165\/11315690-000000000-00000","volume":"69","author":"H Giamarellou","year":"2009","unstructured":"Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs. 2009;69(14):1879\u2013901.","journal-title":"Drugs"},{"issue":"6","key":"669_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.pedneo.2016.10.002","volume":"58","author":"MS Ipek","year":"2017","unstructured":"Ipek MS, Aktar F, Okur N, Celik M, Ozbek E. Colistin use in critically ill neonates: a case\u2013control study. Pediatr Neonatology. 2017;58(6):490\u20136.","journal-title":"Pediatr Neonatology"},{"issue":"4","key":"669_CR12","first-page":"e453","volume":"25","author":"KS Tekgunduz","year":"2015","unstructured":"Tekgunduz KS, Kara M, Caner I, Demirelli Y. Safety and efficacy of intravenous colistin in neonates with culture proven sepsis. Iran J Pediatr. 2015;25(4):e453.","journal-title":"Iran J Pediatr"},{"key":"669_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4103\/0971-5916.198682","volume":"144","author":"B Jasani","year":"2016","unstructured":"Jasani B, Kannan S, Nanavati R, Gogtay NJ, Thatte U. An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country. Indian J Med Res. 2016;144:433\u20139.","journal-title":"Indian J Med Res"},{"issue":"3","key":"669_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","volume":"30","author":"M Jajoo","year":"2011","unstructured":"Jajoo M, Kumar V, Jain M, Kumari S, Manchanda V. Intravenous colistin administration in neonates. Pediatr Infect Dis J. 2011;30(3):218\u201321.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"669_CR15","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1542\/peds.2013-1248","volume":"133","author":"MH Tsai","year":"2014","unstructured":"Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics. 2014;133(2):e322\u20139.","journal-title":"Pediatrics"},{"issue":"9","key":"669_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/archdischild-2019-318067","volume":"105","author":"G Ambreen","year":"2020","unstructured":"Ambreen G, Salat MS, Hussain K, Raza SS, Ali U, Azam I, Iqbal J, Fatmi Z. Efficacy of colistin in multidrug-resistant neonatal sepsis: experience from a tertiary care center in Karachi, Pakistan. Arch Dis Child. 2020;105(9):830\u20136.","journal-title":"Arch Dis Child"},{"issue":"6","key":"669_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3343\/alm.2014.34.6.433","volume":"34","author":"A Ardebili","year":"2014","unstructured":"Ardebili A, Lari AR, Talebi M. Correlation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates. Annals Lab Med. 2014;34(6):433.","journal-title":"Annals Lab Med"},{"issue":"5","key":"669_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40272-018-0301-5","volume":"20","author":"O Ilhan","year":"2018","unstructured":"Ilhan O, Bor M, Ozdemir SA, Akbay S, Ozer EA. Efficacy and safety of intravenous colistin in very low birth weight preterm infants. Paediatr Drugs. 2018;20(5):475\u201381.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"669_CR19","first-page":"174","volume":"25","author":"S Ignak","year":"2020","unstructured":"Ignak S, Coskun Y, Yalcin D, Akman \u0130. The efficacy and nephrological side effects of treatment with Colistin in neonates. Anatol Clin J Med Sci. 2020;25(3):174\u20139.","journal-title":"Anatol Clin J Med Sci"},{"issue":"1","key":"669_CR20","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1017\/ash.2022.33","volume":"2","author":"DP Vyas","year":"2022","unstructured":"Vyas DP, Quinones-Cardona V, Gilfillan MA, Young ME, Pough KA, Carey AJ. Reduction of unnecessary antibiotic days in a level IV neonatal intensive care unit. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e50. 2022.33.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"669_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jhin.2025.05.005","volume":"166","author":"K Ayka\u00e7","year":"2025","unstructured":"Ayka\u00e7 K, \u0130yig\u00fcn I, \u00c7elik T, Ozsurekci Y. Integrating infection prevention into antimicrobial stewardship: a dual strategy for neonatal intensive care unit stewardship. J Hosp Infect. 2025;166:205\u20136. https:\/\/doi.org\/10.1016\/j.jhin.2025.05.005","journal-title":"J Hosp Infect"},{"key":"669_CR22","doi-asserted-by":"publisher","first-page":"1729919","DOI":"10.3389\/fcimb.2025.1729919","volume":"15","author":"T Yang","year":"2025","unstructured":"Yang T, Li H, Xu X, An J, Zhang Z, Li B, Dou Z. Colistin-based combination therapy versus monotherapy for carbapenem-resistant gram-negative bacterial infections: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2025;15:1729919.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"669_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12879-025-10781-1","volume":"25","author":"MJ Alwazzeh","year":"2025","unstructured":"Alwazzeh MJ, Algazaq J, Al-Salem FA, Alabkari F, Alwarthan SM, Alhajri M, AlShehail BM, Alnimr A, Alrefaai AW, Alsaihati FH, Almuhanna FA. Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients. BMC Infect Dis. 2025;25(1):416.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"669_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","volume":"18","author":"M Paul","year":"2018","unstructured":"Paul M, Daikos GL, Durante-Mangoni E, et al. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis. 2018;18(4):391\u2013400.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"669_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/archdischild-2020-320217","volume":"106","author":"C Fleischmann","year":"2021","unstructured":"Fleischmann C, Reichert F, Cassini A, Horner R, Harder T, Markwart R, Tr\u00f6ndle M, Savova Y, Kissoon N, Schlattmann P, Reinhart K. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021;106(8):745\u201352.","journal-title":"Arch Dis Child"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00669-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:40:51Z","timestamp":1790646051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00669-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00669-z","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}